Nifty
Sensex
:
:
13967.50
47409.93
-271.40 (-1.91%)
-937.66 (-1.94%)

Consumer Food

Rating :
59/99

BSE: 531335 | NSE: ZYDUSWELL

1934.60
27-Jan-2021
  • Open
  • High
  • Low
  • Previous Close
  •  1945.60
  •  1955.00
  •  1910.00
  •  1955.85
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  18515
  •  358.52
  •  2218.60
  •  1100.50

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 12,364.04
  • 217.58
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 13,800.67
  • 0.26%
  • 2.81

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 64.82%
  • 2.04%
  • 4.61%
  • FII
  • DII
  • Others
  • 1.59%
  • 10.12%
  • 16.82%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 18.04
  • 34.82
  • 51.05

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.29
  • 28.59
  • 20.71

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.07
  • 6.54
  • 1.91

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 31.74
  • 38.35
  • 48.93

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.92
  • 4.92
  • 4.14

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 26.47
  • 30.35
  • 35.04

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
341.99
326.03
4.90%
537.37
620.25
-13.36%
487.87
416.15
17.23%
332.67
145.41
128.78%
Expenses
314.87
295.58
6.53%
415.02
471.54
-11.99%
383.29
329.68
16.26%
299.97
107.69
178.55%
EBITDA
27.12
30.45
-10.94%
122.35
148.71
-17.73%
104.58
86.47
20.94%
32.70
37.72
-13.31%
EBIDTM
7.93%
9.34%
3.55%
3.55%
14.01%
20.78%
9.83%
25.94%
Other Income
2.81
3.95
-28.86%
1.82
3.03
-39.93%
1.30
8.49
-84.69%
2.43
10.42
-76.68%
Interest
30.83
35.11
-12.19%
34.60
34.85
-0.72%
34.70
28.75
20.70%
35.25
0.46
7,563.04%
Depreciation
6.49
3.82
69.90%
6.42
10.35
-37.97%
6.88
6.28
9.55%
5.34
2.10
154.29%
PBT
-105.34
-14.58
-
15.41
15.41
0.00%
61.47
49.48
24.23%
-5.46
45.58
-
Tax
0.00
-2.56
-
1.10
1.10
0.00%
-7.63
-12.83
-
-9.70
5.16
-
PAT
-105.34
-12.02
-
14.31
14.31
0.00%
69.10
62.31
10.90%
4.24
40.42
-89.51%
PATM
-30.80%
-3.69%
37.11%
37.11%
7.11%
14.97%
1.27%
27.80%
EPS
-16.56
-2.08
-
1.69
1.69
0.00%
28.29
10.81
161.70%
0.74
10.35
-92.85%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
1,699.90
1,766.82
842.82
512.62
430.57
396.68
430.72
403.64
387.99
336.75
336.37
Net Sales Growth
12.74%
109.63%
64.41%
19.06%
8.54%
-7.90%
6.71%
4.03%
15.22%
0.11%
 
Cost Of Goods Sold
4,984.41
636.62
216.44
112.96
91.97
80.86
83.33
123.93
86.60
96.47
113.16
Gross Profit
-3,284.51
1,130.20
626.38
399.66
338.60
315.82
347.39
279.71
301.39
240.28
223.21
GP Margin
-193.22%
63.97%
74.32%
77.96%
78.64%
79.62%
80.65%
69.30%
77.68%
71.35%
66.36%
Total Expenditure
1,413.15
1,445.76
658.02
387.36
331.50
305.35
330.80
314.13
291.37
259.51
251.97
Power & Fuel Cost
-
21.62
9.60
5.15
4.02
3.43
3.58
3.26
2.54
2.78
1.06
% Of Sales
-
1.22%
1.14%
1.00%
0.93%
0.86%
0.83%
0.81%
0.65%
0.83%
0.32%
Employee Cost
-
170.97
82.29
53.61
45.46
39.37
34.21
30.65
27.32
20.61
18.30
% Of Sales
-
9.68%
9.76%
10.46%
10.56%
9.92%
7.94%
7.59%
7.04%
6.12%
5.44%
Manufacturing Exp.
-
191.35
98.14
61.20
51.68
50.65
51.87
10.27
44.99
30.92
7.76
% Of Sales
-
10.83%
11.64%
11.94%
12.00%
12.77%
12.04%
2.54%
11.60%
9.18%
2.31%
General & Admin Exp.
-
63.43
33.60
24.23
23.35
24.77
22.15
20.79
12.82
9.74
6.32
% Of Sales
-
3.59%
3.99%
4.73%
5.42%
6.24%
5.14%
5.15%
3.30%
2.89%
1.88%
Selling & Distn. Exp.
-
340.78
201.38
119.91
105.24
97.16
127.82
117.38
111.04
92.59
94.40
% Of Sales
-
19.29%
23.89%
23.39%
24.44%
24.49%
29.68%
29.08%
28.62%
27.50%
28.06%
Miscellaneous Exp.
-
20.99
16.57
10.30
9.78
9.11
7.84
7.85
6.06
6.40
94.40
% Of Sales
-
1.19%
1.97%
2.01%
2.27%
2.30%
1.82%
1.94%
1.56%
1.90%
3.26%
EBITDA
286.75
321.06
184.80
125.26
99.07
91.33
99.92
89.51
96.62
77.24
84.40
EBITDA Margin
16.87%
18.17%
21.93%
24.44%
23.01%
23.02%
23.20%
22.18%
24.90%
22.94%
25.09%
Other Income
8.36
10.71
38.88
35.06
32.64
32.42
27.59
18.90
15.79
9.01
7.21
Interest
135.38
139.91
30.09
1.70
0.55
0.14
0.13
0.13
0.10
0.15
0.16
Depreciation
25.13
26.39
12.51
8.88
7.16
6.81
7.73
4.65
4.50
3.86
1.49
PBT
-33.92
165.47
181.08
149.74
124.00
116.80
119.65
103.63
107.81
82.24
89.96
Tax
-16.23
-20.45
-0.61
13.23
12.72
11.56
8.50
5.32
8.78
13.65
30.48
Tax Rate
47.85%
-16.86%
-0.36%
8.84%
10.26%
9.90%
7.10%
5.13%
8.14%
16.60%
33.88%
PAT
-17.69
141.72
169.14
133.90
108.98
103.26
108.95
96.45
97.11
67.68
59.48
PAT before Minority Interest
-17.69
141.72
171.24
136.51
111.28
105.24
111.15
98.31
99.03
68.59
59.48
Minority Interest
0.00
0.00
-2.10
-2.61
-2.30
-1.98
-2.20
-1.86
-1.92
-0.91
0.00
PAT Margin
-1.04%
8.02%
20.07%
26.12%
25.31%
26.03%
25.29%
23.90%
25.03%
20.10%
17.68%
PAT Growth
-116.84%
-16.21%
26.32%
22.87%
5.54%
-5.22%
12.96%
-0.68%
43.48%
13.79%
 
EPS
-2.78
22.28
26.59
21.05
17.14
16.24
17.13
15.17
15.27
10.64
9.35

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
3,460.66
3,386.28
691.19
557.19
478.56
406.04
325.56
256.54
186.86
141.89
Share Capital
57.66
57.66
39.07
39.07
39.07
39.07
39.07
39.07
39.07
39.07
Total Reserves
3,403.00
3,328.62
652.12
518.12
439.49
366.97
286.49
217.47
147.79
102.82
Non-Current Liabilities
1,406.41
1,422.99
-71.21
-55.03
5.08
5.22
5.65
4.68
5.33
1.53
Secured Loans
1,500.00
1,500.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
24.37
22.83
0.77
0.74
0.58
0.43
0.37
0.42
0.22
0.02
Current Liabilities
601.82
546.26
121.69
113.46
75.49
89.79
88.94
85.05
74.24
75.61
Trade Payables
491.12
392.29
78.65
66.50
63.20
50.25
49.75
46.24
41.94
41.82
Other Current Liabilities
76.81
71.22
14.86
20.64
11.10
10.71
11.34
8.84
9.33
14.64
Short Term Borrowings
19.05
69.25
25.00
25.00
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
14.84
13.50
3.18
1.32
1.19
28.83
27.85
29.97
22.97
19.15
Total Liabilities
5,468.89
5,355.53
754.83
626.17
567.77
507.91
424.86
349.12
267.36
219.08
Net Block
4,673.52
4,567.42
103.88
102.53
82.07
84.40
95.41
94.26
96.09
58.68
Gross Block
4,843.85
4,711.75
154.42
144.45
117.29
112.85
116.04
110.31
107.76
66.67
Accumulated Depreciation
170.33
144.33
50.54
41.92
35.22
28.45
20.63
16.05
11.67
7.99
Non Current Assets
4,693.10
4,657.83
107.79
109.95
134.82
122.77
121.43
107.71
100.74
96.43
Capital Work in Progress
3.53
10.31
0.24
0.13
0.19
0.24
0.03
0.00
0.00
30.70
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
16.05
80.10
3.07
6.72
52.56
38.13
25.99
13.45
4.65
7.05
Other Non Current Assets
0.00
0.00
0.60
0.57
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
775.79
697.70
647.04
516.22
432.95
385.14
303.43
241.41
166.62
122.65
Current Investments
110.41
46.10
147.55
30.01
94.16
0.00
5.00
0.00
0.00
0.00
Inventories
292.34
233.07
35.06
31.88
24.00
25.99
27.94
40.86
27.41
24.38
Sundry Debtors
118.20
96.04
8.75
4.04
2.76
1.47
2.64
1.45
0.71
1.17
Cash & Bank
82.42
164.29
413.72
440.16
304.53
339.03
262.83
190.79
131.51
89.79
Other Current Assets
172.42
11.37
0.83
1.02
7.50
18.65
5.02
8.31
6.99
7.31
Short Term Loans & Adv.
138.28
146.83
41.13
9.11
7.18
18.32
4.66
7.98
6.51
6.27
Net Current Assets
173.97
151.44
525.35
402.76
357.46
295.35
214.49
156.36
92.38
47.04
Total Assets
5,468.89
5,355.53
754.83
626.17
567.77
507.91
424.86
349.12
267.36
219.08

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
259.25
149.38
69.06
76.95
89.86
69.24
91.09
68.67
62.01
42.90
PBT
121.27
170.63
149.74
124.00
116.80
119.65
103.63
107.81
82.24
89.96
Adjustment
155.61
-7.67
-20.91
-23.03
-24.55
-18.88
-14.21
-10.45
-5.34
-4.59
Changes in Working Capital
-16.03
49.41
-48.05
-15.47
11.77
-20.98
9.06
-23.30
-2.98
-9.54
Cash after chg. in Working capital
260.85
212.37
80.78
85.50
104.02
79.79
98.48
74.06
73.92
75.83
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-1.60
-62.99
-11.72
-8.55
-14.16
-10.55
-7.39
-5.39
-11.91
-32.93
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-83.23
-4,161.65
-59.12
-72.05
-27.83
29.42
13.41
13.35
-2.00
-39.86
Net Fixed Assets
-8.47
-2.34
-1.56
-0.86
-2.12
4.13
-4.11
-0.86
-1.39
Net Investments
161.94
-3,395.90
-39.54
-44.82
-108.99
45.38
-49.92
-48.02
-8.01
Others
-236.70
-763.41
-18.02
-26.37
83.28
-20.09
67.44
62.23
7.40
Cash from Financing Activity
-259.69
4,051.53
-1.82
-6.21
-58.47
-27.46
-27.46
-22.74
-18.29
-13.73
Net Cash Inflow / Outflow
-83.67
39.26
8.12
-1.31
3.56
71.20
77.04
59.28
41.72
-10.69
Opening Cash & Equivalents
138.15
29.59
21.47
22.78
19.22
267.83
190.79
131.51
89.79
100.48
Closing Cash & Equivalent
54.48
138.15
29.59
21.47
22.78
339.03
267.83
190.79
131.51
89.79

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
600.18
587.28
176.91
142.61
122.49
103.93
83.33
65.66
47.83
36.32
ROA
2.62%
5.60%
19.77%
18.64%
19.57%
23.83%
25.40%
32.13%
28.20%
27.15%
ROE
4.14%
8.40%
21.87%
21.49%
23.79%
30.39%
33.78%
44.67%
41.73%
41.92%
ROCE
5.26%
7.08%
23.33%
23.48%
26.44%
32.74%
35.65%
48.67%
50.12%
63.51%
Fixed Asset Turnover
0.37
0.35
3.49
3.53
3.70
3.96
3.80
3.77
3.97
5.05
Receivable days
22.13
22.69
4.48
2.68
1.81
1.66
1.73
0.96
0.99
1.27
Inventory Days
54.27
58.06
23.44
22.05
21.41
21.73
29.17
30.32
27.32
26.45
Payable days
112.80
147.44
72.50
75.57
73.71
58.50
62.36
55.69
62.59
63.10
Cash Conversion Cycle
-36.40
-66.69
-44.58
-50.84
-50.48
-35.12
-31.46
-24.40
-34.28
-35.38
Total Debt/Equity
0.44
0.46
0.04
0.04
0.00
0.00
0.00
0.00
0.00
0.00
Interest Cover
1.87
6.67
89.08
226.45
835.29
921.38
798.15
1079.10
549.27
563.25

News Update:


  • Zydus Wellness expecting to continue growth momentum
    9th Nov 2020, 14:30 PM

    The company would introduce more innovation-based products in the health and hygiene space, a segment heightened after the pandemic

    Read More
  • Zydus Wellness - Quarterly Results
    2nd Nov 2020, 11:39 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.